Palmitoylethanolamide (PEA) is an endogenous fatty acid amide made inside the body when necessary. Since its discovery in 1954 there have been more than five hundred studies aimed at presenting the benefits and safety of palmitoylethanolamide.
Palmitoylethanolamide (PEA) products
However, this does not mean we thought our work was over. Palmitoylethanolamide has one issue that hampers its innate efficacy. Its half-life is very short as it is quickly degraded by two very efficient enzymes in the body – fatty acid amide hydrolase (FAAH) and N-acylethanolamine acid amide hydrolase (NAAA). This means that the positive effects of palmitoylethanolamide are limited by the efficacy of these enzymes.
You can read about our products and PEA in general below